TORIPALIMAB
Clinical trials for TORIPALIMAB explained in plain language.
Never miss a new study
Get alerted when new TORIPALIMAB trials appear
Sign up with your email to follow new studies for TORIPALIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo aims to extend survival in lung cancer patients
Disease control Recruiting nowThis study tests whether adding two drugs, toripalimab and surufatinib, to standard chemoradiotherapy can help people with limited-stage small cell lung cancer live longer without the disease getting worse. About 47 adults aged 18 to 75 with stage I to III small cell lung cancer …
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
New hope for hard-to-treat esophageal cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the drug surufatinib to standard chemotherapy, immunotherapy, and radiation can help people with advanced esophageal cancer that cannot be surgically removed. About 69 adults with this type of cancer will receive the combination treatment. The goal…
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 08:32 UTC